Announced Fri, 25 Sept, 2026 · 18:26 IST
Bal Pharma directors swap executive roles effective Oct 1, 2026
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.7%1-day move
₹107.00
prior close
₹108.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.5-1.9+0.6+4.7+2.4-0.7+0.4-5.2-10.8————
Up moveDown movePending
AI summary
At the 39th AGM on Sep 24, 2026, members approved a swap of executive roles between two existing directors effective Oct 1, 2026. Mr. Ravindra Kumar Kothari moves from Non-Executive Director to Executive Director, while Mr. Virupakshaya Himesh moves from Executive Director to Non-Executive Director. NRC and SRC committees were reconstituted to match. Kothari holds 500 shares; Himesh holds 28,420 shares.
Likely market impact
Internal reshuffle with no net change in board strength. Kothari gains executive role; Himesh steps back to non-executive. Committee seats updated to match.